Balance Sheet Components (Tables)

12 Months Ended

Dec. 31, 2023

Balance Sheet Components [Abstract]

Schedule of Inventory

Inventory consists of the following (in thousands):

	December 31,
	2023		2022
Raw materials	$	2,998	$	—
Work in progress		9,873		5,351
Finished goods		9,441		214
Total inventory	$	22,312	$	5,565

Schedule of Accrued Expenses

Accrued expenses consist of the following (in thousands):

	December 31,
	2023		2022
Accrued compensation and related benefits	$	20,939	$	14,660
Accrued sales deductions		23,650		4,284
Accrued clinical trials		7,268		8,319
Accrued professional service fees		7,941		5,372
Accrued manufacturing and non-clinical costs		9,922		3,927
Accrued royalties payable		6,716		2,456
Accrued interest		2,108		—
Accrued milestone payments		—		15,000
Total accrued expenses	$	78,544	$	54,018